GlassScriptPhysician profile
Madison Dackin
NPI 1225725427
$1,085.55
in general payments reported to CMS, 2019-2025
19 companies · $1,086 in 2025
The $1,086 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,086.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,031 · Education: $54.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,030.56 |
| Education | $54.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $181.73 | 2025 | |
| Genzyme Corporation | $156.40 | 2025 | |
| Glaxosmithkline, LLC. | $107.21 | 2025 | Nucala, Trelegy Ellipta |
| Avadel Cns Pharmaceuticals, LLC | $101.34 | 2025 | Lumryz |
| United Therapeutics Corporation | $57.92 | 2025 | Tyvaso |
| Insmed, INC. | $57.38 | 2025 | Brinsupri, Arikayce |
| Takeda Pharmaceuticals U.S.A., INC. | $55.16 | 2025 | Glassia |
| Baxter Healthcare | $52.53 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $46.32 | 2025 | Ohtuvayre |
| Lilly USA, LLC | $38.54 | 2025 | Zepbound |
| Viatris Specialty LLC | $37.15 | 2025 | Yupelri |
| Genentech USA, INC. | $34.01 | 2025 | Xolair |
| Philips North America LLC | $33.40 | 2025 | Vest Therapy Und |
| Regeneron Healthcare Solutions, INC. | $29.46 | 2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $23.82 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $22.30 | 2025 | Sunosi |
| La Jolla Pharmaceutical Company | $18.64 | 2025 | Giapreza |
| Alexion Pharmaceuticals, INC. | $18.18 | 2025 | Ultomiris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.06 | 2025 | Ofev |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Dackin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.